B. Riley Raises Price Target on LuxExperience to $14
Analyst firm B. Riley increased its price target for LuxExperience from $13 to $14 while maintaining a Buy rating.
Stocks · News reference
Mission Produce rose 5.5% after beating Q3 earnings and sales estimates; several stocks rallied, while ServiceTitan and Evommune fell premarket.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Analyst firm B. Riley increased its price target for LuxExperience from $13 to $14 while maintaining a Buy rating.
Bullish (BLSH) reported Q3 2026 earnings of $0.12 per share, beating consensus estimates of $0.08 and representing a 50% earnings surprise. Revenue of $84.4 million also exceeded expectations by 6.5%. However, the stock has declined 49.1% year-to-date compared to the S&P 500's 7.2% gain. With mixed estimate revisions, Bullish received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market.
B. Riley has increased its price target for Chime Financial, Inc. from $45 to $55 while maintaining a Buy rating.
An insider at Chime Financial, Inc. has sold shares of the company valued at approximately $5.4 million, according to a recent SEC filing.
Casey's General Stores, Inc. will release its second quarter 2027 financial results after the market closes on December 8, 2026, followed by a conference call on December 9, 2026.
InnovAge Holding Corp. has agreed to a $36 million settlement to resolve allegations that it failed to provide timely medical services and specialist referrals to senior patients between 2016 and 2022.